Clinical trial
Docetaxel and Temozolomide in Treating Patients With Metastatic Cancer
NCT00401180 · The Cleveland Clinic, Other · Completed
Key facts
| NCT number | NCT00401180 |
|---|---|
| Title | Docetaxel and Temozolomide in Treating Patients With Metastatic Cancer |
| Official title | Phase I Trial of Weekly Docetaxel and Daily Temozolomide in Patients With Metastatic Disease |
| Lead sponsor | The Cleveland Clinic, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | docetaxel, temozolomide |
| Enrollment | 25 |
| Start date | Jun 1, 2002 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Nov 17, 2006 |
| Last update posted | Jul 8, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: